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Background
Cell saver (CS) may be used during cardiac surgery to
reduce and avoid allogeneic blood transfusion. The aim
of the study was to determine how CS use during cor-
onary artery bypass surgery (CABS) had an effect on
haematological parameters changes before and after sur-
gery, incidence and number of allogeneic blood transfu-
sions and postoperative clinical complications and
mortality.
Methods
The study included sixty patients aged from 39 to
79 years presenting for CABS who were randomized
to control or cell saver groups. We investigated blood
parameters before and after surgery, ejection fraction,
postoperative drainage, intraoperative parameters such
as coronary artery bypass grafting type, number of graft,
extracorporeal circulation and aortic cross clamping
duration as weel as clinical complications and mortality.
Results
There was no statistically significant difference between
groups in haematological parameters changes before and
after surgery (p>0.05). The CS use significantly reduced
allogeneic transfusion requirements (p<0.05). Although
there was less clinical complications in the group receiv-
ing CS, significant difference between groups in surgical
outcomes that were presented as incidence of post-
operative complications and mortality was not reached
(p>0.05).
Conclusion
The CS use during CABS reduced allogeneic transfusion
requirements which are a great benefit in CABS. On the
other hand, the effects of the CS on important outcomes
such as postoperative clinical complications and mortal-
ity remain unproven.
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